HEATHER HIGGINS: Open Payments
NPI 1770005316 · BESSEMER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$918 in 32 payments from 11 companies in 2025. Trend: 2023 $118 · 2024 $335 · 2025 $918
Food & beverage: $850Education: $68
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 7 | $235 |
| Janssen Biotech, Inc. | 3 | $189 |
| Sumitomo Pharma America, Inc. | 9 | $150 |
| Endo USA, Inc. | 5 | $99 |
| GlaxoSmithKline, LLC. | 1 | $86 |
| IMMUNITYBIO, INC. | 2 | $43 |
| Boston Scientific Corporation | 1 | $31 |
| PFIZER INC. | 1 | $27 |
| Myriad Genetic Laboratories, Inc. | 1 | $22 |
| Verity Pharmaceuticals Inc. | 1 | $19 |
Products named: XYOSTED, GEMTESA, RYBREVANT, XIAFLEX, BLUJEPA, ERLEADA, ANKTIVA, SpaceOAR VUE System - 10mL.
Industry payments across AL — which companies pay providers there.
